Počet záznamov: 1
PD-1 is a regulator of NY-ESO-1-Specific CD8+ T cell expansion in melanoma patients
Názov PD-1 is a regulator of NY-ESO-1-Specific CD8+ T cell expansion in melanoma patients Autor Fourcade J. Spoluautori Kúdela Pavol 1975- Spoluautori Andrade P. Janjic B. Land S. Sander C. Krieg A. Donnenberg A. Shen H. Kirkwood J. Zarour H. Zdroj.dok. The Journal of immunology : Official Journal of the American Association of Immunologists. Vol. 182, no. 9 (2009) p. 5240-5249 Jazyk dok. eng - angličtina Krajina US - Spojené štáty Druh dok. rozpis článkov z periodík (rbx) Ohlasy PUVVADA, S.D. - LI, H.L. - RIMSZA, L.M. - BERNSTEIN, S.H. - FISHER, R.I. - LEBLANC, M. - SCHMELZ, M. - GLINSMANN-GIBSON, B. - MILLER, T.P. - MADDOX, A.M. - FRIEDBERG, J.W. - SMITH, S.M. - PERSKY, D.O. A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520. In LEUKEMIA & LYMPHOMA. ISSN 1042-8194, OCT 2016, vol. 57, no. 10, p. 2359-2369. SHIMIZU, T. - SETO, T. - HIRAI, F. - TAKENOYAMA, M. - NOSAKI, K. - TSURUTANI, J. - KANEDA, H. - IWASA, T. - KAWAKAMI, H. - NOGUCHI, K. - SHIMAMOTO, T. - NAKAGAWA, K. Phase 1 study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced solid tumors. In INVESTIGATIONAL NEW DRUGS. ISSN 0167-6997, JUN 2016, vol. 34, no. 3, p. 347-354. REISER, J. - BANERJEE, A. Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response. In JOURNAL OF IMMUNOLOGY RESEARCH. ISSN 2314-8861, 2016. MARCQ, E. - PAUWELS, P. - VAN MEERBEECK, J.P. - SMITS, E.L.J. Targeting immune checkpoints: New opportunity for mesothelioma treatment?. In CANCER TREATMENT REVIEWS. ISSN 0305-7372, DEC 2015, vol. 41, no. 10, p. 914-924. WANG, D.Z. - DUBOIS, R.N. Immunosuppression associated with chronic inflammation in the tumor microenvironment. In CARCINOGENESIS. ISSN 0143-3334, OCT 2015, vol. 36, no. 10, p. 1085-1093. YANG, Q.Q. - JIANG, W.C. - ZHUANG, C.B. - GENG, Z. - HOU, C. - HUANG, D. - HU, L.H. - WANG, X.B. microRNA-22 downregulation of galectin-9 influences lymphocyte apoptosis and tumor cell proliferation in liver cancer. In ONCOLOGY REPORTS. ISSN 1021-335X, OCT 2015, vol. 34, no. 4, p. 1771-1778. XU, B.L. - YUAN, L. - GAO, Q.L. - YUAN, P. - ZHAO, P. - YUAN, H.J. - FAN, H.J. - LI, T.P. - QIN, P. - HAN, L. - FANG, W.J. - SUO, Z.H. Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer. In ONCOTARGET. ISSN 1949-2553, AUG 21 2015, vol. 6, no. 24, p. 20592-20603. KISSICK, H.T. - SANDA, M.G. The role of active vaccination in cancer immunotherapy: lessons from clinical trials. In CURRENT OPINION IN IMMUNOLOGY. ISSN 0952-7915, AUG 2015, vol. 35, p. 15-22. KAMPHORST, A.O. - ARAKI, K. - AHMED, R. Beyond adjuvants: Immunomodulation strategies to enhance T cell immunity. In VACCINE. ISSN 0264-410X, JUN 8 2015, vol. 33, p. B21-B28. JIANG, Y. - LI, Y. - ZHU, B. T-cell exhaustion in the tumor microenvironment. In CELL DEATH & DISEASE. ISSN 2041-4889, JUN 2015, vol. 6. BAKSH, K. - WEBER, J. Immune Checkpoint Protein Inhibition for Cancer: Preclinical Justification for CTLA-4 and PD-1 Blockade and New Combinations. In SEMINARS IN ONCOLOGY. ISSN 0093-7754, JUN 2015, vol. 42, no. 3, p. 363-377. BEAVIS, P.A. - MILENKOVSKI, N. - HENDERSON, M.A. - JOHN, L.B. - ALLARD, B. - LOI, S. - KERSHAW, M.H. - STAGG, J. - DARCY, P.K. Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell Responses. In CANCER IMMUNOLOGY RESEARCH. ISSN 2326-6066, MAY 2015, vol. 3, no. 5, p. 506-517. PAUKEN, K.E. - WHERRY, E.J. Overcoming T cell exhaustion in infection and cancer. In TRENDS IN IMMUNOLOGY. ISSN 1471-4906, APR 2015, vol. 36, no. 4, p. 265-276. YE, B. - LIU, X. - LI, X. - KONG, H. - TIAN, L. - CHEN, Y. T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance. In CELL DEATH & DISEASE. ISSN 2041-4889, MAR 2015, vol. 6. MASUCCI, G.V. - DE PETRIS, L. - LUNDQVIST, A. - KIESSLING, R. - LEWENSOHN, R. T Cell Blockade Immunotherapy Against Cancer and Abscopal Effect in Combination Therapy. In DEVELOPMENTS IN T CELL BASED CANCER IMMUNOTHERAPIES. 2015, p. 211-229. DANNULL, J. - TAN, C.R. - FARRELL, C. - WANG, C. - PRUITT, S. - NAIR, S.K. - LEE, W.T. Gene Expression Profile of Dendritic Cell-Tumor Cell Hybrids Determined by Microarrays and Its Implications for Cancer Immunotherapy. In JOURNAL OF IMMUNOLOGY RESEARCH. ISSN 2314-8861, 2015. APETOH, L. - SMYTH, M.J. - DRAKE, C.G. - ABASTADO, J.P. - APTE, R.N. - AYYOUB, M. - BLAY, J.Y. - BONNEVILLE, M. - BUTTERFIELD, L.H. - CAIGNARD, A. - CASTELLI, C. - CAVALLO, F. - CELIS, E. - CHEN, L.P. - COLOMBO, M.P. - COMIN-ANDUIX, B. - COUKOS, G. - DHODAPKAR, M.V. - DRANOFF, G. - FRAZER, I.H. - FRIDMAN, W.H. - GABRILOVICH, D.I. - GILBOA, E. - GNJATIC, S. - JAGER, D. - KALINSKI, P. - KAUFMAN, H.L. - KIESSLING, R. - KIRKWOOD, J. - KNUTH, A. - LIBLAU, R. - LOTZE, M.T. - LUGLI, E. - MARINCOLA, F. - MELERO, I. - MELIEF, C.J. - MEMPEL, T.R. - MITTENDORF, E.A. - ODUN, K. - OVERWIJK, W.W. - PALUCKA, A.K. - PARMIANI, G. - RIBAS, A. - ROMERO, P. - SCHREIBER, R.D. - SCHULER, G. - SRIVASTAVA, P.K. - TARTOUR, E. - VALMORI, D. - VAN DER BURG, S.H. - VAN DER BRUGGEN, P. - VAN DEN EYNDE, B.J. - WANG, E. - ZOU, W.P. - WHITESIDE, T.L. - SPEISER, D.E. - PARDOLL, D.M. - RESTIFO, N.P. - ANDERSON, A.C. Consensus nomenclature for CD8(+) T cell phenotypes in cancer. In ONCOIMMUNOLOGY. ISSN 2162-402X, 2015, vol. 4, no. 4. WU, X. - ZHANG, H. - XING, Q. - CUI, J. - LI, J. - LI, Y. - TAN, Y. - WANG, S. PD-1(+) CD8(+) T cells are exhausted in tumours and functional in draining lymph nodes of colorectal cancer patients. In BRITISH JOURNAL OF CANCER. ISSN 0007-0920, SEP 23 2014, vol. 111, no. 7, p. 1391-1399. GYORKI, D.E. - SPILLANE, J. - SPEAKMAN, D. - SHACKLETON, M. - HENDERSON, M.A. Current management of advanced melanoma: a transformed landscape. In ANZ JOURNAL OF SURGERY. ISSN 1445-1433, SEP 2014, vol. 84, no. 9, p. 612-617. MANSFIELD, A.S. - RODEN, A.C. - PEIKERT, T. - SHEININ, Y.M. - HARRINGTON, S.M. - KRCO, C.J. - DONG, H.D. - KWON, E.D. B7-H1 Expression in Malignant Pleural Mesothelioma is Associated with Sarcomatoid Histology and Poor Prognosis. In JOURNAL OF THORACIC ONCOLOGY. ISSN 1556-0864, JUL 2014, vol. 9, no. 7, p. 1036-1040. FEHRES, C.M. - UNGER, W.W.J. - GARCIA-VALLEJO, J.J. - VAN KOOYK, Y. Understanding the biology of antigen cross-presentation for the design of vaccines against cancer. In FRONTIERS IN IMMUNOLOGY. ISSN 1664-3224, APR 8 2014, vol. 5. DEMOTTE, N. - BIGIRIMANA, R.E. - WIEERS, G. - STROOBANT, V. - SQUIFFLET, J.L. - CARRASCO, J. - THIELEMANS, K. - BAURAIN, J.F. - VAN DER SMISSEN, P. - COURTOY, P.J. - VAN DER BRUGGEN, P. A Short Treatment with Galactomannan GM-CT-01 Corrects the Functions of Freshly Isolated Human Tumor-Infiltrating Lymphocytes. In CLINICAL CANCER RESEARCH. ISSN 1078-0432, APR 1 2014, vol. 20, no. 7, p. 1823-1833. SALERNO, E.P. - OLSON, W.C. - MCSKIMMING, C. - SHEA, S. - SLINGLUFF, C.L. T cells in the human metastatic melanoma microenvironment express site-specific homing receptors and retention integrins. In INTERNATIONAL JOURNAL OF CANCER. ISSN 0020-7136, FEB 1 2014, vol. 134, no. 3, p. 563-574. SELIGER, B. B7-H Abnormalities in Melanoma and Clinical Relevance. In MOLECULAR DIAGNOSTICS FOR MELANOMA: METHODS AND PROTOCOLS. ISSN 1064-3745, 2014, vol. 1102, p. 367-380. TAN, C.R. - DANNULL, J. - NAIR, S.K. - DING, E.Y. - TYLER, D.S. - PRUITT, S.K. - LEE, W.T. Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccination. In JOURNAL OF SURGICAL RESEARCH. ISSN 0022-4804, DEC 2013, vol. 185, no. 2, p. 904-911. PETROVAS, C. - YAMAMOTO, T. - PRICE, D.A. - RAO, S.S. - KLATT, N.R. - BRENCHLEY, J.M. - DOUEK, D.C. - GOSTICK, E. - ANGERMANN, B.R. - GROSSMAN, Z. - MACALLAN, D.C. - MEIER-SCHELLERSHEIM, M. - KOUP, R.A. High Production Rates Sustain In Vivo Levels of PD-1(high) Simian Immunodeficiency Virus-Specific CD8 T Cells in the Face of Rapid Clearance. In JOURNAL OF VIROLOGY. ISSN 0022-538X, SEP 2013, vol. 87, no. 17, p. 9836-9844. GYORKI, D.E. - YUAN, J. - MU, Z.Y. - ZAIDI, B. - PULITZER, M. - BUSAM, K. - BRADY, M.S. - COIT, D.G. - ALLISON, J.P. - WOLCHOK, J.D. - ARIYAN, C.E. Immunological Insights from Patients Undergoing Surgery on Ipilimumab for Metastatic Melanoma. In ANNALS OF SURGICAL ONCOLOGY. ISSN 1068-9265, SEP 2013, vol. 20, no. 9, p. 3106-3111. WEI, F. - ZHONG, S. - MA, Z.Y. - KONG, H. - MEDVEC, A. - AHMED, R. - FREEMAN, G.J. - KROGSGAARD, M. - RILEY, J.L. Strength of PD-1 signaling differentially affects T-cell effector functions. In PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. ISSN 0027-8424, JUL 2 2013, vol. 110, no. 27, p. E2480-E2489. CALLAHAN, M.K. - WOLCHOK, J.D. At the Bedside: CTLA-4-and PD-1-blocking antibodies in cancer immunotherapy. In JOURNAL OF LEUKOCYTE BIOLOGY. ISSN 0741-5400, JUL 2013, vol. 94, no. 1, p. 41-53. SCARPATI, G.D.V. - FUSCIELLO, C. - SABBATINO, F. - FERRONE, S. - CAPONIGRO, F. - PERRI, F. - CARLOMAGNO, C. - PEPE, S. Multidisciplinary Approach to Patient with Malignant Melanoma. In ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. ISSN 1871-5206, JUL 2013, vol. 13, no. 6, p. 887-900. TAN, C.R. - REDDY, V. - DANNULL, J. - DING, E.Y. - NAIR, S.K. - TYLER, D.S. - PRUITT, S.K. - LEE, W.T. Impact of anti-CD25 monoclonal antibody on dendritic cell-tumor fusion vaccine efficacy in a murine melanoma model. In JOURNAL OF TRANSLATIONAL MEDICINE. ISSN 1479-5876, JUN 17 2013, vol. 11. KAMPHORST, A.O. - AHMED, R. Manipulating the PD-1 pathway to improve immunity. In CURRENT OPINION IN IMMUNOLOGY. ISSN 0952-7915, JUN 2013, vol. 25, no. 3, p. 381-388. MOCELLIN, S. - BENNA, C. - PILATI, P. Coinhibitory molecules in cancer biology and therapy. In CYTOKINE & GROWTH FACTOR REVIEWS. ISSN 1359-6101, APR 2013, vol. 24, no. 2, p. 147-161. PASERO, C. - OLIVE, D. Interfering with coinhibitory molecules: BTLA/HVEM as new targets to enhance anti-tumor immunity. In IMMUNOLOGY LETTERS. ISSN 0165-2478, MAR 2013, vol. 151, no. 1-2, p. 71-75. MERAZ, I.M. - SEGURA-IBARRA, V. - LEONARD, F. - GONZALEZ, J. - ALLY, S. - GODIN, B. - SERDA, R.E. Biological Microniches Characterizing Pathological Lesions: Impact on Nanoparticle-Based Delivery of Therapeutics. In NANOMEDICINE. ISSN 1876-2778, 2013, vol. 5, p. 139-173. OMORI, R. - EGUCHI, J. - HIROISHI, K. - ISHII, S. - HIRAIDE, A. - SAKAKI, M. - DOI, H. - KAJIWARA, A. - ITO, T. - KOGO, M. - IMAWARI, M. Effects of interferon-alpha-transduced tumor cell vaccines and blockade of programmed cell death-1 on the growth of established tumors. In CANCER GENE THERAPY. ISSN 0929-1903, SEP 2012, vol. 19, no. 9, p. 637-643. BRENTVILLE, V.A. - METHERINGHAM, R.L. - GUNN, B. - DURRANT, L.G. High Avidity Cytotoxic T Lymphocytes Can Be Selected into the Memory Pool but They Are Exquisitely Sensitive to Functional Impairment. In PLOS ONE. ISSN 1932-6203, JUL 19 2012, vol. 7, no. 7. CHANDRA, S. - PAVLICK, A.C. Targeted Therapies for Metastatic Melanoma. In DERMATOLOGIC CLINICS. ISSN 0733-8635, JUL 2012, vol. 30, no. 3, p. 517-+. BARUAH, P. - LEE, M. - ODUTOYE, T. - WILLIAMSON, P. - HYDE, N. - KASKI, J.C. - DUMITRIU, I.E. Decreased levels of alternative co-stimulatory receptors OX40 and 4-1BB characterise T cells from head and neck cancer patients. In IMMUNOBIOLOGY. ISSN 0171-2985, JUL 2012, vol. 217, no. 7, p. 669-675. KRONIG, H. - FALCHNER, K.J. - ODENDAHL, M. - BRACKERTZ, B. - CONRAD, H. - MUCK, D. - HEIN, R. - BLANK, C. - PESCHEL, C. - HALLER, B. - SCHULZ, S. - BERNHARD, H. PD-1 expression on Melan-A-reactive T cells increases during progression to metastatic disease. In INTERNATIONAL JOURNAL OF CANCER. ISSN 0020-7136, MAY 15 2012, vol. 130, no. 10, p. 2327-2336. TOPALIAN, S.L. - DRAKE, C.G. - PARDOLL, D.M. Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity. In CURRENT OPINION IN IMMUNOLOGY. ISSN 0952-7915, APR 2012, vol. 24, no. 2, p. 207-212. CHACON, J.A. - HWU, P. - RADVANYI, L.G. Adoptive Cell Therapy for the Treatment of Metastatic Melanoma. In TARGETED THERAPEUTICS IN MELANOMA. 2012, p. 233-272. POLLACK, S.M. - YEE, C. Adoptive Immunotherapy of Melanoma. In INNATE IMMUNE REGULATION AND CANCER IMMUNOTHERAPY. 2012, p. 439-465. OOSTERHOFF, D. - SLUIJTER, B.J.R. - HANGALAPURA, B.N. - DE GRUIJL, T.D. The Dermis as a Portal for Dendritic Cell-Targeted Immunotherapy of Cutaneous Melanoma. In INTRADERMAL IMMUNIZATION. ISSN 0070-217X, 2012, vol. 351, p. 181-220. YUAN, J.D. - ADAMOW, M. - GINSBERG, B.A. - RASALAN, T.S. - RITTER, E. - GALLARDO, H.F. - XU, Y.Y. - POGORILER, E. - TERZULLI, S.L. - KUK, D. - PANAGEAS, K.S. - RITTER, G. - SZNOL, M. - HALABAN, R. - JUNGBLUTH, A.A. - ALLISON, J.P. - OLD, L.J. - WOLCHOK, J.D. - GNJATIC, S. Integrated NY-ESO-1 antibody and CD8(+) T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab. In PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. ISSN 0027-8424, OCT 4 2011, vol. 108, no. 40, p. 16723-16728. ZENG, Z. - SHI, F. - ZHOU, L. - ZHANG, M.N. - CHEN, Y. - CHANG, X.J. - LU, Y.Y. - BAI, W.L. - QU, J.H. - WANG, C.P. - WANG, H. - LOU, M. - WANG, F.S. - LV, J.Y. - YANG, Y.P. Upregulation of Circulating PD-L1/PD-1 Is Associated with Poor Post-Cryoablation Prognosis in Patients with HBV-Related Hepatocellular Carcinoma. In PLOS ONE. ISSN 1932-6203, SEP 1 2011, vol. 6, no. 9. THANGAVELU, G. - ANDERSON, C.C. An essential role for programmed death-1 in the control of autoimmunity: implications for the future of hematopoietic stem cell transplantation. In FUTURE ONCOLOGY. ISSN 1479-6694, AUG 2011, vol. 7, no. 8, p. 929-932. SAKUISHI, K. - JAYARAMAN, P. - BEHAR, S.M. - ANDERSON, A.C. - KUCHROO, V.K. Emerging Tim-3 functions in antimicrobial and tumor immunity. In TRENDS IN IMMUNOLOGY. ISSN 1471-4906, AUG 2011, vol. 32, no. 8, p. 345-349. SIERRO, S.R. - DONDA, A. - PERRET, R. - GUILLAUME, P. - YAGITA, H. - LEVY, F. - ROMERO, P. Combination of lentivector immunization and low-dose chemotherapy or PD-1/PD-L1 blocking primes self-reactive T cells and induces anti-tumor immunity. In EUROPEAN JOURNAL OF IMMUNOLOGY. ISSN 0014-2980, AUG 2011, vol. 41, no. 8, p. 2217-2228. DURRANT, L.G. - PUDNEY, V.A. - SPENDLOVE, I. Using monoclonal antibodies to stimulate antitumor cellular immunity. In EXPERT REVIEW OF VACCINES. ISSN 1476-0584, JUL 2011, vol. 10, no. 7, p. 1093-1106. KLEIN, O. - SCHMIDT, C. - KNIGHTS, A. - DAVIS, I.D. - CHEN, W.S. - CEBON, J. Melanoma vaccines: developments over the past 10 years. In EXPERT REVIEW OF VACCINES. ISSN 1476-0584, JUN 2011, vol. 10, no. 6, SI, p. 853-873. JIN, H.T. - JEONG, Y.H. - PARK, H.J. - HA, S.J. Mechanism of T cell exhaustion in a chronic environment. In BMB REPORTS. ISSN 1976-6696, APR 30 2011, vol. 44, no. 4, p. 217-231. WANG, S.F. - FOUQUET, S. - CHAPON, M. - SALMON, H. - REGNIER, F. - LABROQUERE, K. - BADOUAL, C. - DAMOTTE, D. - VALIDIRE, P. - MAUBEC, E. - DELONGCHAMPS, N.B. - CAZES, A. - GIBAULT, L. - GARCETTE, M. - DIEU-NOSJEAN, M.C. - ZERBIB, M. - AVRIL, M.F. - PREVOST-BLONDEL, A. - RANDRIAMAMPITA, C. - TRAUTMANN, A. - BERCOVICI, N. Early T Cell Signalling Is Reversibly Altered in PD-1(+) T Lymphocytes Infiltrating Human Tumors. In PLOS ONE. ISSN 1932-6203, MAR 7 2011, vol. 6, no. 3. WEBER, J. Immunotherapy for melanoma. In CURRENT OPINION IN ONCOLOGY. ISSN 1040-8746, MAR 2011, vol. 23, no. 2, p. 163-169. STEWART, T.J. - SMYTH, M.J. Improving cancer immunotherapy by targeting tumor-induced immune suppression. In CANCER AND METASTASIS REVIEWS. ISSN 0167-7659, MAR 2011, vol. 30, no. 1, SI, p. 125-140. VAN DEN HEUVEL, M.J. - GARG, N. - VAN KAER, L. - HAERYFAR, S.M.M. NKT cell costimulation: experimental progress and therapeutic promise. In TRENDS IN MOLECULAR MEDICINE. ISSN 1471-4914, FEB 2011, vol. 17, no. 2, p. 65-77. KULEMZIN, S.V. - ZAMOSHNIKOVA, A.Y. - YURCHENKO, M.Y. - VITAK, N.Y. - NAJAKSHIN, A.M. - FAYNGERTS, S.A. - CHIKAEV, N.A. - RESHETNIKOVA, E.S. - KASHIRINA, N.M. - PECLO, M.M. - RUTKEVICH, P.N. - SHEVELEV, A.Y. - YANUSHEVSKAYA, E.V. - BARANOV, K.O. - MAMONKIN, M. - VLASIK, T.N. - SIDORENKO, S.P. - TARANIN, A.V. - MECHETINA, L.V. FCRL6 receptor: Expression and associated proteins. In IMMUNOLOGY LETTERS. ISSN 0165-2478, JAN 30 2011, vol. 134, no. 2, SI, p. 174-182. DISIS, M.L. Immune Regulation of Cancer. In JOURNAL OF CLINICAL ONCOLOGY. ISSN 0732-183X, OCT 10 2010, vol. 28, no. 29, p. 4531-4538. WEBER, J. Immune Checkpoint Proteins: A New Therapeutic Paradigm for Cancer-Preclinical Background: CTLA-4 and PD-1 Blockade. In SEMINARS IN ONCOLOGY. ISSN 0093-7754, OCT 2010, vol. 37, no. 5, p. 430-439. SAKUISHI, K. - APETOH, L. - SULLIVAN, J.M. - BLAZAR, B.R. - KUCHROO, V.K. - ANDERSON, A.C. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. In JOURNAL OF EXPERIMENTAL MEDICINE. ISSN 0022-1007, SEP 27 2010, vol. 207, no. 10, p. 2187-2194. SERRIARI, N.E. - GONDOIS-REY, F. - GUILLAUME, Y. - REMMERSWAAL, E.B.M. - PASTOR, S. - MESSAL, N. - TRUNEH, A. - HIRSCH, I. - VAN LIER, R.A.W. - OLIVE, D. B and T Lymphocyte Attenuator Is Highly Expressed on CMV-Specific T Cells during Infection and Regulates Their Function. In JOURNAL OF IMMUNOLOGY. ISSN 0022-1767, SEP 15 2010, vol. 185, no. 6, p. 3140-3148. MURAOKA, D. - KATO, T. - WANG, L.A. - MAEDA, Y. - NOGUCHI, T. - HARADA, N. - TAKEDA, K. - YAGITA, H. - GUILLAUME, P. - LUESCHER, I. - OLD, L.J. - SHIKU, H. - NISHIKAWA, H. Peptide Vaccine Induces Enhanced Tumor Growth Associated with Apoptosis Induction in CD8(+) T Cells. In JOURNAL OF IMMUNOLOGY. ISSN 0022-1767, SEP 15 2010, vol. 185, no. 6, p. 3768-3776. GUILLAUME, P. - BAUMGAERTNER, P. - NEFF, L. - RUFER, N. - WETTSTEIN, P. - SPEISER, D.E. - LUESCHER, I.F. Novel soluble HLA-A2/MELAN-A complexes selectively stain a differentiation defective subpopulation of CD8+T cells in patients with melanoma. In INTERNATIONAL JOURNAL OF CANCER. ISSN 0020-7136, AUG 15 2010, vol. 127, no. 4, p. 910-923. WOLCHOK, J.D. - YANG, A.S. - WEBER, J.S. Immune Regulatory Antibodies Are They the Next Advance?. In CANCER JOURNAL. ISSN 1528-9117, JUL-AUG 2010, vol. 16, no. 4, p. 311-317. O'REILLY, R.J. - DAO, T. - KOEHNE, G. - SCHEINBERG, D. - DOUBROVINA, E. Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation. In SEMINARS IN IMMUNOLOGY. ISSN 1044-5323, JUN 2010, vol. 22, no. 3, p. 162-172. MATSUZAKI, J. - GNJATIC, S. - MHAWECH-FAUCEGLIA, P. - BECK, A. - MILLER, A. - TSUJI, T. - EPPOLITO, C. - QIAN, F. - LELE, S. - SHRIKANT, P. - OLD, L.J. - ODUNSI, K. Tumor-infiltrating NY-ESO-1-specific CD8(+) T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer. In PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. ISSN 0027-8424, APR 27 2010, vol. 107, no. 17, p. 7875-7880. KIM, P.S. - AHMED, R. Features of responding T cells in cancer and chronic infection. In CURRENT OPINION IN IMMUNOLOGY. ISSN 0952-7915, APR 2010, vol. 22, no. 2, p. 223-230. JANDUS, C. - SPEISER, D. - ROMERO, P. Recent advances and hurdles in melanoma immunotherapy. In PIGMENT CELL & MELANOMA RESEARCH. ISSN 1755-1471, DEC 2009, vol. 22, no. 6, p. 711-723. DE SOUZA, A.P. - BONORINO, C. Tumor immunosuppressive environment: effects on tumor-specific and nontumor antigen immune responses. In EXPERT REVIEW OF ANTICANCER THERAPY. ISSN 1473-7140, SEP 2009, vol. 9, no. 9, p. 1317-1332. KOIDO, S. - HARA, E. - HOMMA, S. - NAMIKI, Y. - OHKUSA, T. - GONG, J.L. - TAJIRI, H. Cancer Vaccine by Fusions of Dendritic and Cancer Cells. In CLINICAL & DEVELOPMENTAL IMMUNOLOGY. ISSN 1740-2522, 2009. GHOLAMI, Mohammad Davoodzadeh - KARDAR, Gholam Ali - SAEEDI, Yousef - HEYDARI, Sahel - GARSSEN, Johan - FALAK, Reza. Exhaustion of T lymphocytes in the tumor microenvironment: Significance and effective mechanisms. In CELLULAR IMMUNOLOGY. ISSN 0008-8749, DEC 2017, vol. 322, p. 1-14. MIAO, Jie - LU, Xu - HU, Yuefeng - PIAO, Chunmei - WU, Xuan - LIU, Xuesong - HUANG, Caiting - WANG, Yue - LI, Dan - LIU, Jingwei. Prostaglandin E-2 and PD-1 mediated inhibition of antitumor CTL responses in the human tumor microenvironment. In ONCOTARGET. ISSN 1949-2553, OCT 27 2017, vol. 8, no. 52, p. 89802-89810. LI, Hongshan - YU, Jingyu - LIU, Chao - LIU, Jiang - SUBRAMANIAM, Sriram - ZHAO, Hong - BLUMENTHAL, Gideon M. - TURNER, David C. - LI, Claire - AHAMADI, Malidi - DE GREEF, Rik - CHATTERJEE, Manash - KONDIC, Anna G. - STONE, Julie A. - BOOTH, Brian P. - KEEGAN, Patricia - RAHMAN, Atiqur - WANG, Yaning. Time dependent pharmacokinetics of pembrolizumab in patients with solid tumor and its correlation with best overall response. In JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS. ISSN 1567-567X, OCT 2017, vol. 44, no. 5, p. 403-414. OKOYE, Isobel S. - HOUGHTON, Michael - TYRRELL, Lorne - BARAKAT, Khaled - ELAHI, Shokrollah. Coinhibitory Receptor expression and immune Checkpoint Blockade: Maintaining a Balance in CD8(+) T Cell Responses to Chronic viral infections and Cancer. In FRONTIERS IN IMMUNOLOGY. ISSN 1664-3224, SEP 29 2017, vol. 8. VILAIN, Ricardo E. - MENZIES, Alexander M. - WILMOTT, James S. - KAKAVAND, Hojabr - MADORE, Jason - GUMINSKI, Alexander - LINIKER, Elizabeth - KONG, Benjamin Y. - COOPER, Adam J. - HOWLE, Julie R. - SAW, Robyn P. M. - JAKROT, Valerie - LO, Serigne - THOMPSON, John F. - CARLINO, Matteo S. - KEFFORD, Richard F. - LONG, Georgina V. - SCOLYER, Richard A. Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma. In CLINICAL CANCER RESEARCH. ISSN 1078-0432, SEP 1 2017, vol. 23, no. 17, p. 5024-5033. GRANIER, Clemence - DE GUILLEBON, Eleonore - BLANC, Charlotte - ROUSSEL, Helene - BADOUAL, Cecile - COLIN, Elia - SALDMANN, Antonin - GEY, Alain - OUDARD, Stephane - TARTOUR, Eric. Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer. In ESMO OPEN. ISSN 2059-7029, JUN 2017, vol. 2, no. 2. LU, Xu - YANG, Lin - YAO, Daxing - WU, Xuan - LI, Jingpo - LIU, Xuesong - DENG, Lijuan - HUANG, Caiting - WANG, Yue - LI, Dan - LIU, Jingwei. Tumor antigen-specific CD8(+) T cells are negatively regulated by PD-1 and Tim-3 in human gastric cancer. In CELLULAR IMMUNOLOGY. ISSN 0008-8749, MAR 2017, vol. 313, p. 43-51. LIU, Xin-guang - HOU, Ming - LIU, Yu. TIGIT, A Novel Therapeutic Target for Tumor Immunotherapy. In IMMUNOLOGICAL INVESTIGATIONS. ISSN 0882-0139, FEB 2017, vol. 46, no. 2, p. 172-182. CATAKOVIC, Kemal - KLIESER, Eckhard - NEUREITER, Daniel - GEISBERGER, Roland. T cell exhaustion: from pathophysiological basics to tumor immunotherapy. In CELL COMMUNICATION AND SIGNALING. ISSN 1478-811X, JAN 5 2017, vol. 15. BU, Xia - YAO, Yihui - LI, Xiaoyu. Immune Checkpoint Blockade in Breast Cancer Therapy. In TRANSLATIONAL RESEARCH IN BREAST CANCER: BIOMARKER DIAGNOSIS, TARGETED THERAPIES AND APPROACHES TO PRECISION MEDICINE. ISSN 0065-2598, 2017, vol. 1026, p. 383-402. ALBU, Diana I. - WANG, Zichun - HUANG, Kuan-Chun - WU, Jiayi - TWINE, Natalie - LEACU, Sarah - INGERSOLL, Christy - PARENT, Lana - LEE, Winnie - LIU, Diana - WRIGHT-MICHAUD, Renee - KUMAR, Namita - KUZNETSOV, Galina - CHEN, Qian - ZHENG, Wanjun - NOMOTO, Kenichi - WOODALL-JAPPE, Mary - BAO, Xingfeng. EP4 Antagonism by E7046 diminishes Myeloid immunosuppression and synergizes with Treg-reducing IL-2-Diphtheria toxin fusion protein in restoring anti-tumor immunity. In ONCOIMMUNOLOGY. ISSN 2162-402X, 2017, vol. 6, no. 8. JACQUELOT, Nicolas - PITT, Jonathan M. - ENOT, David P. - ROBERTI, Maria Paula - DUONG, Connie P. M. - RUSAKIEWICZ, Sylvie - EGGERMONT, Alexander M. - ZITVOGEL, Laurence. Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanoma. In ONCOIMMUNOLOGY. ISSN 2162-402X, 2017, vol. 6, no. 8. KUMAR, Rajeev - YU, Fang - ZHEN, Yuan-Huan - LI, Bo - WANG, Jun - YANG, Yuan - GE, Hui-Xin - HU, Ping-Sheng - XIU, Jin. PD-1 blockade restores impaired function of ex vivo expanded CD8+T cells and enhances apoptosis in mismatch repair deficient EpCACAM+PD-L1+cancer cells. In ONCOTARGETS AND THERAPY. ISSN 1178-6930, 2017, vol. 10, p. 3453-3465. KENDRICK, Samantha - RIMSZA, Lisa M. - SCOTT, David W. - SLACK, Graham W. - FARINHA, Pedro - TAN, King L. - PERSKY, Daniel - PUVVADA, Soham - CONNORS, Joseph M. - SEHN, Laurie - GASCOYNE, Randy D. - SCHMELZ, Monika. Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma. In VIRCHOWS ARCHIV. ISSN 0945-6317, JAN 2017, vol. 470, no. 1, p. 113-117. Kategória ADCA - Vedecké práce v zahraničných karentovaných časopisoch impaktovaných Kategória (od 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Typ výstupu článok Rok vykazovania 2009 Registrované v WOS Registrované v SCOPUS DOI 10.4049/jimmunol.0803245 
článok
rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2009 2008 6.000 Q1 4.609 Q1
Počet záznamov: 1